CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 25,250
-250 (-0.98%)
At close: Feb 6, 2026
CellBion Market Cap
CellBion has a market cap or net worth of 324 billion as of February 6, 2026. Its market cap has increased by 94.10% in one year.
Market Cap
324.00B
Enterprise Value
302.88B
Revenue
2.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
25,250.00
Market Cap Chart
Since October 16, 2024, CellBion's market cap has increased from 263.06B to 324.00B, an increase of 23.16%. That is a compound annual growth rate of 17.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 324.00B | 6.99% |
| Dec 30, 2025 | 302.82B | 100.48% |
| Dec 30, 2024 | 151.05B | -42.58% |
| Oct 16, 2024 | 263.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 719.40B |
| Samyang Biopharm | 696.00B |
| HEM Pharma | 633.63B |
| DAE HWA Pharmaceutical | 264.85B |
| NOVAREX | 253.85B |
| Vivozon Pharmaceutical | 226.69B |
| Organoidsciences | 193.61B |
| GREEN CROSS WellBeing | 167.69B |